LOBELobe Sciences Ltd.
0.0800CAD+14.29%Mkt Cap: 16.83M $P/E:

Lobe Sciences Ltd., a biopharmaceutical company, engages in the research and development of lipid technology to develop innovative treatments for orphan and rare diseases. It offers Altemia® MF, a medical food designed t…

Key Statistics

Company
Market Cap16.83M $
Enterprise Value15.37M $
Revenue (TTM)
Gross Profit0 $
Net Income (TTM)-3.22M $
Revenue/Share
Last Price0.0800 CAD
Fiscal Year EndAug 2025
MR QuarterMay 2026
Employees
CountryCA
SectorHealthcare
IndustryBiotechnology
ISIN
Valuation
P/E (Trailing)
P/E (Forward)
PEG
EV/EBITDA
EV/Revenue
P/S
P/B11.43
EPS (TTM)-0.04
EPS (Forward)
52W Range
0.030033% of range0.1800
52W High0.1800 CAD
52W Low0.0300 CAD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-187.94%
ROA-58.34%
Growth
Revenue Growth
Earnings Growth
Cash Flow & Leverage
Operating CF-1.03M $
CapEx (TTM)
FCF Margin
FCF Yield-16.83%
Net Debt-3.55M $
Net Debt/EBITDA
Balance Sheet
Debt/Equity0.12
Current Ratio2.38
Quick Ratio2.24
Book Value/Sh0.0070 CAD
Cash/Share0.0170 CAD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 CAD
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Splits
Last Split1:6
Split DateJun 10, 2022
Analyst Consensus
Rating
Target (Mean)
Target Range
# Analysts
Ownership
Shares Out.308.18M
Float108.97M
Insiders63.62%
Institutions0.00%
Short Interest
Short Ratio0.1d
Short % Out.0.00%
Shares Short692
Short (prev mo.)417
Technical
SMA 500.0905 (-11.6%)
SMA 2000.0754 (+6.1%)
Beta-0.06
S&P 52W Chg18.16%
Avg Vol (30d)50.83K
Avg Vol (10d)137.39K
Technical Indicators
RSI (14)40.2
MACD-0.0049
MACD Signal-0.0027
MACD Hist.-0.0022
BB Upper0.1177 CAD
BB Middle0.0963 CAD
BB Lower0.0748 CAD
BB Width44.66%
ATR (14)0.0118 CAD
Vol Ratio (20d)6.97x